CXCL1 and neoplasm: Overexpression of DEC2 in OSCC cells induced dormancy and resistance to cisplatin, while CAF-derived CXCL1 downregulated DEC2, confirmed by qRT-PCR results, leading to the reactivation of dormant cells and contributing to tumor recurrence (188).